Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases.

Biotechnology

Cimeio Therapeutics

Cimeio Therapeutics' headquarters in Basel, Switzerland

Daniel Stark

Saniye Yumlu

Stefanie Urlinger

Rosalba Lepore

Lukas Jeker

Sophie Lackner

Toni Cathomen

Corey Cutler

Fyodor Urnov

Suneet Agarwal

Alexander Mayweg

Michael Tomsicek

Jeff Bluestone

Markus Enzelberger

The Scientific Research and Development team at Cimeio Therapeutics is dedicated to advancing the company's gene editing, cellular, and immunotherapy technologies. This team, comprising experts in molecular biology, protein engineering, cell therapy, preclinical models, CMC analytical development, computational biology, and gene editing, collaborates to develop and optimize Shielded-Cell & Immunotherapy Pairs targeting serious and life-threatening diseases. Their work spans from fundamental research and preclinical development to translational studies aimed at bringing innovative therapies to patients in need.

Scientific Research and Development

The Board Members at Cimeio Therapeutics provide strategic oversight, governance, and guidance to the company's executive team. They ensure that the company's mission of developing Shielded-Cell & Immunotherapy Pairs is effectively pursued, while also addressing regulatory, financial, and ethical considerations.

Board Members

The Leadership Team at Cimeio Therapeutics steers the company’s strategic direction and operational execution in developing advanced gene editing and immunotherapy solutions. Comprised of experts in manufacturing, scientific research, medical strategy, and finance, this team collaborates to drive innovation, ensure compliance with regulatory standards, and maximize clinical and commercial success in addressing serious and life-threatening diseases.

Leadership Team

The Chief Officers team at Cimeio Therapeutics comprises the Chief Medical Officer, Chief Financial Officer, Chief Manufacturing Officer, and Chief Scientific Officer. Together, they provide strategic leadership and oversight, ensuring the company effectively advances its gene editing, cellular, and immunotherapy treatments from research and development through to clinical application and commercialization, while managing financial health and operational efficiency.

Cimeio Therapeutics

Org chart

Board & advisors

Teams

Scientific Research and Development

Board Members

Leadership Team

Chief Officers

Offices

Cimeio Therapeutics

Org chart

Board & advisors

Teams

Scientific Research and Development

Board Members

Leadership Team

Chief Officers

Offices

Related companies